HCPLive Network
Latest Oncology Headlines
Wednesday, October 22, 2014
By Christina Izzo
Janssen Research & Development, LLC, has submitted a supplemental New Drug Application for ibrutinib (Imbruvica) as treatment for patients with Waldenström's macroglobulinemia (WM).
Wednesday, October 22, 2014
Access to an employer-sponsored private price transparency platform is associated with reduced total claims payments, according to research published in the Oct. 22/29 issue of the Journal of the American Medical Association.
Wednesday, October 22, 2014
By Gina Battaglia, PhD
Substantial clinical trial evidence supports the use of pathologic complete response (pCR) as a measure for evaluating neoadjuvant therapies for patients with HER2-positive breast cancer, suggesting that preoperative treatment should be the standard of care
Tuesday, October 21, 2014
By Andrew J. Roth
Ibrutinib has been approved by the European Commission for the treatment of adult patients with relapsed or refractory MCL and adult patients with CLL.
Tuesday, October 21, 2014
By Beth Fand Incollingo
Despite the promise associated with biomarker-based tools as a means of helping to guide cancer diagnosis and treatment, there is a potential stumbling block: insurance reimbursement.
Tuesday, October 21, 2014
A state law that requires plaintiffs to release relevant protected health information before proceeding with allegations of medical liability has been upheld by a federal appeals court, according to the American Medical Association.
Tuesday, October 21, 2014
Unplanned hospitalizations among elderly patients with gastrointestinal cancer are common, according to research published online Oct. 6 in the Journal of Clinical Oncology.
Tuesday, October 21, 2014
By Tony Berberabe, MPH
It seems like big data is everywhere these days. It’s being touted as a solution for physicians and practices who would like to participate in Accountable Care Organizations (ACOs) and accountable care-like contracts with payers.
Monday, October 20, 2014
By Silas Inman
The FDA has granted a fast track designation to TAS-102 (tipiracil hydrochloride) as a treatment for patients with refractory metastatic colorectal cancer (mCRC), according to an announcement by Taiho Oncology, the company developing the drug in the United States.
Monday, October 20, 2014
The Medical College Admission Test has been revised, and the latest changes, including more humanities such as social sciences, are due to be implemented next April, according to a report from the Association of American Medical Colleges.
Monday, October 20, 2014
The incidence of young-onset colorectal cancer is increasing, and the disease is more aggressive pathologically. These findings are being presented at the annual meeting of the American College of Gastroenterology, held from Oct. 17 to 22 in Philadelphia.
Monday, October 20, 2014
By Silas Inman
The treatment of patients with chronic lymphocytic leukemia (CLL) has undergone a dramatic transformation in the past year, with the approval of the novel oral agents ibrutinib (Imbruvica) and idelalisib (Zydelig).
Monday, October 20, 2014
From 2001 to 2010 the volume of patient-to-physician electronic messages increased, but the rate per-capita stabilized, according to research published in the October issue of Health Affairs.
Monday, October 20, 2014
A simple formula can reliably predict whether there will be sufficient blood flow to deep inferior epigastric perforator flap pedicles in women undergoing breast reconstruction using the advanced DIEP technique, according to a study published online Oct. 3 in Plastic Reconstructive Surgery Global Open.
Monday, October 20, 2014
By Jacqueline Claudia Barrientos, MD
The treatment landscape for patients with chronic lymphocytic leukemia (CLL) is rapidly changing, with the emergence of four new therapeutic options for this malignancy in recent months.
Sunday, October 19, 2014
By Christina Izzo
The treatment of patients with non-small cell lung cancer (NSCLC) who harbor an actionable mutation in EGFR or ALK continues evolve, as clinical trials begin exploring next-generation agents and combination strategies.
Saturday, October 18, 2014
By Surabhi Dangi-Garimella, PhD
Stem cell therapy has gained increasing traction in various therapeutic areas, from cancer to diabetes to ocular regeneration.
Friday, October 17, 2014
Differential expression of long noncoding RNAs identified in prostate cancer cell lines, patient tissue samples, and patient urine samples can detect prostate cancer, according to a study published in the November issue of the Journal of Molecular Diagnostics.
Friday, October 17, 2014
For patients with node-negative breast cancer (NNBC), the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making, according to a study published online Oct. 6 in the Journal of Clinical Oncology.
Friday, October 17, 2014
A Manhattan Research survey recently found that many physicians believe digital communication technologies, including mobile apps, can be used to improve patient outcomes, according to an article published Oct. 8 in Medical Economics.
Physician's Money Digest
Most Social Security beneficiaries (58 million) will receive the benefit increase in January. The 8 million Supplemental Security Income recipients will see increased payments as of Dec. 31.
Tests and diagnostic procedures often help physicians discover conditions or formulate treatments, but researchers say some tests are used far more often than they are worth. Here are 5 tests and procedures physicians should think twice about before prescribing.